Protocol summary

Summary
Objective: Comparison of oral dydrogesterone with vaginal cyclogest for luteal support in IUI cycles. Design: A randomized multicenter clinical trial. Setting and conduct and participants including major eligibility criteria: 150 women younger than 35 years old with unexplained infertility, Proper ovulation, 2 open tubal, Not having severe or moderate problem of man and without a history of previous abdominal surgery were included in this study. Informed consent was obtained from all patients. All women received a daily 75 IU FSH and they underwent ultrasonography on 8-9 days of the menstrual. In patients who had 3-4 follicles with a diameter of more than 18 mm, HCG to release oocytes was injected and IUI was performed 36 hours later. 2 days after IUI, Patients randomly were divided in two groups: Group A or oral dydrogesterone group (n=75) and group B or vaginal cyclogest group.Group A received 10 mg dydrogesterone twice per day and group B received 400 mg vaginal progesterone once per night. Progesterone administration was continued until 12 weeks of pregnancy. Finally, Pregnancy rates, Abortion rates, Serum levels of progesterone (on day 21 of the menstrual cycle; 7 days after IUI) and patient satisfaction in both groups were compared. Main outcome measures: Clinical pregnancy rate. Second outcomes measures: Progestrone serum level and miscarriage rates and patient acceptance.

General information

Acronym
IRCT registration information
IRCT registration number: IRCT2015010220408N2
Registration date: 2015-01-18, 1393/10/28
Registration timing: registered_while_recruiting

Last update:
Update count: 0
Registration date
2015-01-18, 1393/10/28
Registrant information
Name
Robabeh Taheripanah
Name of organization / entity
Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Country
Iran (Islamic Republic of)
Phone
+98 21 2243 2558
Email address
taheripanahf@sbmu.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice chancellor for research, Shahid Beheshti University of Medical Science
Expected recruitment start date
2014-03-20, 1392/12/29
Expected recruitment end date
2015-01-20, 1393/10/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of oral dydrogesterone with vaginal cyclogest for luteal support in IUI cycles
Public title
progestrone effect on pregnancy
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria; Women younger than 35 years old with unexplained infertility; Proper ovulation; 2 open tubal; Not having severe or moderate problem of man and without a history of previous abdominal surgery. Exclusion criteria; Advanced endometriosis; Dense pelvic adhesion; Genital TB; Patients who did not reffer for following up.
Age
From 18 years old to 35 years old
Gender
Female
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size: 148
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Double blinded
Blinding description
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Infertility & Reproductive Health Research Center Ethics committee of Shahid Beheshti University of
Street address
3rd floor, Taleghani Hospital, Velenjak, Shahid Chamran highway
City
tehran
Postal code
1985711151
Approval date
2014-03-11, 1392/12/20
Ethics committee reference number
149

Health conditions studied

1

Description of health condition studied
Other complications associated with artificial fertilization
ICD-10 code
N98
ICD-10 code description
Noninflammatory disorders of female genital tract

Primary outcomes

1

Description
Clinical pregnancy rate
Timepoint
two weeks after start of intervention
Method of measurement
Transvaginal ultrasonography and pregnancy test

Secondary outcomes

1

Description
Miscariage rate
Timepoint
Until 24 weeks after start of intervention
Method of measurement
History, Physical exam, Ultrasonography

2

Description
Patients acceptance
Timepoint
Untill 12 weeks
Method of measurement
Questionare

3

Description
progestrone serum level
Timepoint
one week after start of intervention
Method of measurement
measure of blood progestrone

Intervention groups

1

Description
Intervention: Duphaston(Oral Didrogesterone 10mg) 20mg , Twice daily until 12 weeks.
Category
Treatment - Drugs

2

Description
Intervention: Vaginal progesterone( Cyclogest 400 microgram) Daily until 12 weeks
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Infertility & Reproductive Health Research Center Shahid Beheshti University of Medical Science
Full name of responsible person
donya khosravi
Street address
Taleghani hospital, Velenjak, Shahid Chamran highway, Tehran
City
tehran

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Vice chancellor for research, Shahid Beheshti University of Medical Science
Full name of responsible person
zahra sadegh zadeh
Street address
3rd floor, Taleghani Hospital, Velenjak, Shahid Chamran highway
City
tehran
Grant name
معاونت پژوهشی دانشگاه علوم پزشکی شهیدبهشتی
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Vice chancellor for research, Shahid Beheshti University of Medical Science
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty

Person responsible for general inquiries

Contact
Name of organization / entity
Infertility & Reproductive Health Research Centre - Shahid Beheshti of Medical Science
Full name of responsible person
robabeh taheripanah
Position
Assistant professor of gynecology group
Other areas of specialty/work
Street address
Taleghani Hospital, Velenjak, Shahid Chamran highway
City
tehran
Postal code
1985711151
Phone
+98 21 2243 2558
Fax
+98 21 2243 2600
Email
taheripanahf@gmail.com
Web page address
www.irhrc.sbmu.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Infertility & Reproductive Health Research Centre - Shahid Beheshti of Medical Science
Full name of responsible person
robabeh taheripanah
Position
Assistant professor of gynecology group
Other areas of specialty/work
Street address
Taleghani Hospital, Velenjak, Shahid Chamran highway
City
tehran
Postal code
1985711151
Phone
+98 21 2243 2558
Fax
Email
taheripanahf@gmail.com
Web page address
www.irhrc.sbmu.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Infertility & Reproductive Health Research Centre - Shahid Beheshti of Medical Science
Full name of responsible person
robabeh taheripanah
Position
Assistant professor of gynecology group
Other areas of specialty/work
Street address
Taleghani Hospital, Velenjak, Shahid Chamran highway
City
tehran
Postal code
1985711151
Phone
+98 21 2243 2558
Fax
+98 21 2243 2600
Email
taheripanahf@gmail.com
Web page address
www.irhrc.sbmu.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
empty
Study Protocol
empty
Statistical Analysis Plan
empty
Informed Consent Form
empty
Clinical Study Report
empty
Analytic Code
empty
Data Dictionary
empty
Loading...